# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-009983
Filing Date
2018-07-13
Accepted
2018-07-13 16:27:05
Documents
85
Period of Report
2018-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm | 10-Q | 1264033
2 |  | ex31-1.htm | EX-31.1 | 18175
3 |  | ex31-2.htm | EX-31.2 | 18113
4 |  | ex32-1.htm | EX-32.1 | 7212
5 |  | ex32-2.htm | EX-32.2 | 7102
| Complete submission text file | 0001493152-18-009983.txt |  | 5223496

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL INSTANCE FILE | aker-20180331.xml | EX-101.INS | 809842
7 | XBRL SCHEMA FILE | aker-20180331.xsd | EX-101.SCH | 66403
8 | XBRL CALCULATION FILE | aker-20180331_cal.xml | EX-101.CAL | 66014
9 | XBRL DEFINITION FILE | aker-20180331_def.xml | EX-101.DEF | 229495
10 | XBRL LABEL FILE | aker-20180331_lab.xml | EX-101.LAB | 426321
11 | XBRL PRESENTATION FILE | aker-20180331_pre.xml | EX-101.PRE | 342176

Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 18952760
SIC: 2835 In Vitro & In Vivo Diagnostic Substances